UPDATE!
The Literature Nobel will be announced on Thursday 6th October.
Starting today with the prize for physiology or medicine the Nobel prize winners for 2011 will be announced over the next 10 days.
The schedule for the announcements is:
- October 3rd: Physiology or medicine
- October 4th: Physics
- October 5th: Chemistry
??October 13th?? October 6th : Literature (According to tradition, the Swedish Academy has not yet set the date for its announcement of the Nobel Prize in Literature)- October 7th: Peace
- October 10th: Economic sciences (Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel
- Robert L. Coffman Vice President and Chief Scientific Officer, Dynavax Technologies, Berkeley, CA USA
WHY: with Timothy R. Mosmann, for their discovery of two types of T lymphocytes, TH1 and TH2, and their role in regulating host immune response
- Brian J. Druker JELD-WEN Chair of Leukemia Research, and Director, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland OR USA
WHY: with Nicholas B. Lydon and Charles L. Sawyers for their development of imatinib and dasatinib, revolutionary, targeted treatments for chronic myeloid leukemia
- Robert S. Langer David H. Koch Institute Professor, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA USA
WHY: with Joseph P. Vacanti, for their pioneering research in tissue engineering and regenerative medicine
- Nicholas B. Lydon Founder, Granite Biopharma, LLC, Jackson Hole, WY USA; Co-founder and Director, AnaptysBio, San Diego, CA USA; and Co-founder and Director, Blueprint Medicines, Cambridge, MA USA
WHY: with Brian J. Druker and Charles L. Sawyers for their development of imatinib and dasatinib, revolutionary, targeted treatments for chronic myeloid leukemia
- Jacques F. A. P. Miller Emeritus Professor, Walter and Eliza Hall Institute of Medical Research and the University of Melbourne, Parkville, Melbourne, Australia
WHY: for his discovery of the function of the thymus and the identification of T cells and B cells in mammalian species
- Timothy R. Mosmann Professor, Department of Microbiology and Immunology, and Michael and Angela Pichichero Director in the David H. Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, University of Rochester, Rochester, NY USA
WHY: with Robert L. Coffman, for their discovery of two types of T lymphocytes, TH1 and TH2, and their role in regulating host immune response
- Charles L. Sawyers Marie-Josée and Henry R. Kravis Chair in Human Oncology and Pathogenesis, Memorial Sloan-Kettering Cancer Center, New York, NY USA. Also, Howard Hughes Medical Institute Investigator
WHY: with Brian J. Druker and Nicholas B. Lydon Charles L. Sawyers for their development of imatinib and dasatinib, revolutionary, targeted treatments for chronic myeloid leukemia
- Joseph P. Vacanti John Homans Professor of Surgery, Harvard Medical School; Surgeon-in-Chief and Chief of the Department of Pediatric Surgery and Director of the Laboratory for Tissue Engineering and Organ Fabrication, Massachusetts General Hospital, Boston, MA USA
WHY: with Robert S. Langer, for their pioneering research in tissue engineering and regenerative medicine
The k2p blog 